Projects per year
Fingerprint
Dive into the research topics where Benjamin A. Gartrell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
Halmos, B. (PI), Gartrell, B. A. (CoPI), Rapkin, B. D. (CoPI), Einstein, M. H. (CoPI), Ohri, N. (CoPI) & Sparano, J. A. (CoPI)
8/1/14 → 7/31/25
Project: Research project
-
18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study
Rais-Bahrami, S., Fleming, M., Gartrell, B., Lavely, W. C., Chau, A., Davis, P. & Schuster, D. M., Sep 2024, In: Advances in Radiation Oncology. 9, 9, 101571.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
Shen, J., Chowdhury, S., Agarwal, N., Karsh, L. I., Oudard, S., Gartrell, B. A., Feyerabend, S., Saad, F., Pieczonka, C. M., Chi, K. N., Brookman-May, S. D., Rooney, B., Bhaumik, A., McCarthy, S. A., Bevans, K. B., Mundle, S. D., Small, E. J., Smith, M. R. & Graff, J. N., Jan 31 2024, In: British Journal of Cancer. 130, 1, p. 73-81 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review
Gartrell, B. A., Phalguni, A., Bajko, P., Mundle, S. D., McCarthy, S. A., Brookman-May, S. D., De Solda, F., Jain, R., Yu Ko, W., Ploussard, G. & Hadaschik, B., Dec 1 2024, In: European urology oncology. 7, 6, p. 1216-1227 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
The CLEAR Trial Investigators, Apr 10 2024, In: Journal of Clinical Oncology. 42, 11, p. 1222-1228 7 p.Research output: Contribution to journal › Article › peer-review
Open Access35 Scopus citations -
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Gulati, S., Barata, P. C., Elliott, A., Bilen, M. A., Burgess, E. F., Choueiri, T. K., Darabi, S., Dawson, N. A., Gartrell, B. A., Hammers, H. J., Heath, E. I., Magee, D., Rao, A., Ryan, C. J., Twardowski, P., Wei, S., Brugarolas, J., Zhang, T., Zibelman, M. R. & Nabhan, C. & 1 others, , Jul 15 2024, In: Journal of Clinical Investigation. 134, 14, e176230.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations